Section 2 - Composition, Information on Ingredients

CAS#	Chemical Name	Percent	EINECS/ELINCS
50-00-0	Formaldehyde	3.7	200-001-8
67-56-1	Methyl alcohol	1.5	200-659-6
7558-79-4	Sodium phosphate dibasic	<1.0	231-448-7
7558-80-7	Sodium phosphate monobasic	<1.0	231-449-2
7732-18-5	Deionized Water	Balance	231-791-2

Section 3 - Hazards Identification

Appearance: colorless liquid. Flash Point: > 200 deg F.
Warning! Harmful if inhaled. Harmful if absorbed through the skin. Contains formaldehyde which can cause cancer. May cause severe skin irritation. May cause allergic respiratory and skin reaction. May cause respiratory tract irritation. May cause eye irritation and transient injury. May cause lung damage. May cause pulmonary edema. May cause reproductive and fetal effects.
Target Organs: Lungs, respiratory system, eyes, skin.


Potential Health Effects
Eye: May cause severe eye irritation. May result in corneal injury.
Skin: May cause skin irritation. May cause severe skin irritation. Harmful if absorbed through the skin. May cause skin sensitization, an allergic reaction, which becomes evident upon re-exposure to this material. In severe cases may produce blistering, scaling and cracking.
Ingestion: Harmful if swallowed. May cause irritation of the digestive tract. Ingestion may cause violent vomiting and diarrhea leading to collapse. May cause systemic toxicity including central nervous system depression, convulsions, coma, and possible death due to respiratory
Inhalation: Harmful if inhaled. May cause irritation of the respiratory tract with burning pain in the nose and throat, coughing, wheezing, shortness of breath and pulmonary edema. May cause asthmatic attacks due to allergic sensitization of the respiratory tract. May cause pulmonary edema and severe respiratory disturbances.
Chronic: Contains formaldehyde which can cause cancer in humans. There is sufficient evidence that formaldehyde causes nasopharyngeal cancer in humans, a rare cancer in developed countries. There is limited evidence that formaldehyde causes cancer of the nasal cavity and paranasal sinuses and strong but not sufficient evidence for leukemia.

Section 4 - First Aid Measures

Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed.
Skin: Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion: If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation: Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician: Treat symptomatically and supportively.

Section 5 - Fire Fighting Measures

General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Water runoff can cause environmental damage. Dike and collect water used to fight fire. Use water spray to keep fire-exposed containers cool.
Extinguishing Media: For small fires, use water spray, dry chemical, carbon dioxide or chemical foam.
Flash Point: > 200e deg F (> 93.33 deg C)
Autoignition Temperature: Not applicable.
Explosion Limits, Lower:Not available.
Upper: Not available.
NFPA Rating: (estimated) Health: 2; Flammability: 1; Instability: 0

Section 6 - Accidental Release Measures

General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks: Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation. Urea based materials are available which can be used to bind the formaldehyde forming a polymer.

Section 7 - Handling and Storage

Handling: Wash thoroughly after handling. Wash hands before eating. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Do not ingest or inhale. Use only with adequate ventilation.
Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - Exposure Controls, Personal Protection

Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. See 29CFR 1910.1048 for regulatory requirements pertaining to all occupational exposures to formaldehyde, i.e., from formaldehyde gas, its solutions, and materials that release formaldehyde.
Exposure Limits

Chemical Name	ACGIH	NIOSH	OSHA - Final PELs
Formaldehyde	0.3 ppm Ceiling	0.016 ppm TWA 20 ppm IDLH	0.75 ppm TWA; 2 ppm STEL; 0.5 ppm Action Level (Irritant and potential cancer ha zard - see 29 CFR 1910.1048)
Methyl alcohol	200 ppm TWA; 250 ppm STEL; skin - potential for cutaneous absorption	200 ppm TWA; 260 mg/m3 TWA 6000 ppm IDLH	200 ppm TWA; 260 mg/m3 TWA
Sodium phosphate dibasic	none listed	none listed	none listed
Sodium phosphate monobasic	none listed	none listed	none listed
Deionized Water	none listed	none listed	none listed

OSHA Vacated PELs: Formaldehyde: 3 ppm TWA (unless specified in 1910.1048) Methyl alcohol: 200 ppm TWA; 260 mg/m3 TWA Sodium phosphate dibasic: No OSHA Vacated PELs are listed for this chemical. Sodium phosphate monobasic: No OSHA Vacated PELs are listed for this chemical. Deionized Water: No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes: Wear chemical goggles.
Skin: Wear appropriate protective gloves to prevent skin exposure.
Clothing: Wear appropriate protective clothing to prevent skin exposure.
Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary.

Section 9 - Physical and Chemical Properties

Physical State: Liquid
Appearance: colorless
Odor: Characteristic odor.
pH: 7.0 +/-0.1@25C
Vapor Pressure: Not available.
Vapor Density: >1 (Air= 1)
Evaporation Rate:Similar to water.
Viscosity: Not available.
Boiling Point: 102 deg C
Freezing/Melting Point:Not available.
Decomposition Temperature:Not available.
Solubility: Completely soluble in water.
Specific Gravity/Density:1.0 (Water=1)
Molecular Formula:Not applicable.
Molecular Weight:Not available.

Section 10 - Stability and Reactivity

Chemical Stability: Stable under normal temperatures and pressures.
Conditions to Avoid: Ignition sources, confined spaces.
Incompatibilities with Other Materials: Strong oxidizing agents.
Hazardous Decomposition Products: Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - Toxicological Information

RTECS#:      
CAS# 50-00-0: LP8925000      
CAS# 67-56-1: PC1400000      
CAS# 7558-79-4: WC4500000      
CAS# 7558-80-7: WA1900000      
CAS# 7732-18-5: ZC0110000
LD50/LC50:
CAS# 50-00-0:
     Draize test, rabbit, eye: 750 ug/24H Severe;
     Draize test, rabbit, eye: 750 ug Severe;
     Draize test, rabbit, eye: 10 mg Severe;
     Draize test, rabbit, eye: 37% Severe;
     Draize test, rabbit, skin: 2 mg/24H Severe;
     Draize test, rabbit, skin: 50 mg/24H Moderate;
     Inhalation, mouse: LC50 = 454 mg/m3/4H;
     Inhalation, mouse: LC50 = 505 mg/m3/2H;
     Inhalation, rat: LC50 = 203 mg/m3;
     Inhalation, rat: LC50 = 578 mg/m3/2H;
     Inhalation, rat: LC50 = 250 ppm/2H;
     Oral, mouse: LD50 = 42 mg/kg;
     Oral, mouse: LD50
CAS# 67-56-1:
     Draize test, rabbit, eye: 40 mg Moderate;
     Draize test, rabbit, eye: 100 mg/24H Moderate;
     Draize test, rabbit, skin: 20 mg/24H Moderate;
     Inhalation, rabbit: LC50 = 81000 mg/m3/14H;
     Inhalation, rat: LC50 = 64000 ppm/4H;
     Oral, mouse: LD50 = 7300 mg/kg;
     Oral, rabbit: LD50 = 14200 mg/kg;
     Oral, rat: LD50 = 5600 mg/kg;
     Skin, rabbit: LD50 = 15800 mg/kg;
CAS# 7558-79-4:
     Draize test, rabbit, eye: 500 mg/24H Mild;
     Draize test, rabbit, skin: 500 mg/24H Mild;
     Oral, rat: LD50 = 17 gm/kg;
CAS# 7558-80-7:
     Draize test, rabbit, eye: 150 mg Mild;
     Oral, rat: LD50 = 8290 mg/kg;
CAS# 7732-18-5:
     Oral, rat: LD50 = >90 mL/kg;
Carcinogenicity:
CAS# 50-00-0:

• ACGIH: A2 - Suspected Human Carcinogen
  
• California: carcinogen, initial date 1/1/88 (gas)
  
• NTP: Suspect carcinogen
  
• IARC: Group 1 carcinogen